JP2022536122A5 - - Google Patents
Info
- Publication number
- JP2022536122A5 JP2022536122A5 JP2021572597A JP2021572597A JP2022536122A5 JP 2022536122 A5 JP2022536122 A5 JP 2022536122A5 JP 2021572597 A JP2021572597 A JP 2021572597A JP 2021572597 A JP2021572597 A JP 2021572597A JP 2022536122 A5 JP2022536122 A5 JP 2022536122A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cells
- tumor
- protein
- active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025120504A JP2025157424A (ja) | 2019-06-07 | 2025-07-17 | 腫瘍関連抗原特異的ｔ細胞応答 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962858756P | 2019-06-07 | 2019-06-07 | |
| US62/858,756 | 2019-06-07 | ||
| US201962878511P | 2019-07-25 | 2019-07-25 | |
| US62/878,511 | 2019-07-25 | ||
| PCT/US2020/036481 WO2020247859A2 (en) | 2019-06-07 | 2020-06-05 | Tumor-associated antigen-specific t cell responses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120504A Division JP2025157424A (ja) | 2019-06-07 | 2025-07-17 | 腫瘍関連抗原特異的ｔ細胞応答 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022536122A JP2022536122A (ja) | 2022-08-12 |
| JP2022536122A5 true JP2022536122A5 (https=) | 2023-06-12 |
Family
ID=73653372
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021572597A Pending JP2022536122A (ja) | 2019-06-07 | 2020-06-05 | 腫瘍関連抗原特異的ｔ細胞応答 |
| JP2025120504A Pending JP2025157424A (ja) | 2019-06-07 | 2025-07-17 | 腫瘍関連抗原特異的ｔ細胞応答 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120504A Pending JP2025157424A (ja) | 2019-06-07 | 2025-07-17 | 腫瘍関連抗原特異的ｔ細胞応答 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220257740A1 (https=) |
| EP (1) | EP3980071A4 (https=) |
| JP (2) | JP2022536122A (https=) |
| CN (1) | CN114206385A (https=) |
| WO (1) | WO2020247859A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023115459A1 (zh) * | 2021-12-23 | 2023-06-29 | 青岛华赛伯曼医学细胞生物有限公司 | 一种肿瘤抗原/mhc-i复合物及其制备方法和用途 |
| JP2025508970A (ja) * | 2022-03-02 | 2025-04-10 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Ｈｌａ－ａ＊０２：０１制限ヒト前立腺酸性ホスファターゼ（ｐａｐ）エピトープとの反応性を示すヒトｔ細胞受容体対 |
| GB202406990D0 (en) * | 2024-05-16 | 2024-07-03 | Univ Oxford Innovation Ltd | T cell receptors and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000031542A1 (en) * | 1998-11-24 | 2000-06-02 | Thomas Jefferson University | Detection of t cell stimulating tumor antigens |
| AU2008312444B2 (en) * | 2007-10-18 | 2014-02-06 | Bavarian Nordic A/S | Use of MVA to treat prostate cancer |
| EP2337795A2 (en) * | 2008-10-01 | 2011-06-29 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| TR201802741T4 (tr) * | 2010-05-14 | 2018-03-21 | Univ Oregon Health & Science | Rekombinant hcmv ve rhcmv vektörleri ve bunların kullanımları. |
| JP6816031B2 (ja) * | 2015-02-10 | 2021-01-20 | オレゴン ヘルス アンド サイエンス ユニバーシティ | 非標準的なｃｄ８＋ｔ細胞応答を生成するのに有用な方法および組成物 |
| CN108474003A (zh) * | 2015-11-20 | 2018-08-31 | 俄勒冈健康与科学大学 | 包含微小rna识别元件的cmv载体 |
| CN109843321A (zh) * | 2016-06-22 | 2019-06-04 | 国际艾滋病疫苗行动组织公司 | 作为结核病疫苗的重组巨细胞病毒载体 |
| US10532099B2 (en) * | 2016-10-18 | 2020-01-14 | Oregon Health & Science University | Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules |
-
2020
- 2020-06-05 JP JP2021572597A patent/JP2022536122A/ja active Pending
- 2020-06-05 US US17/616,941 patent/US20220257740A1/en active Pending
- 2020-06-05 CN CN202080055529.7A patent/CN114206385A/zh active Pending
- 2020-06-05 EP EP20818177.6A patent/EP3980071A4/en active Pending
- 2020-06-05 WO PCT/US2020/036481 patent/WO2020247859A2/en not_active Ceased
-
2025
- 2025-07-17 JP JP2025120504A patent/JP2025157424A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021191265A5 (https=) | ||
| RU2360923C2 (ru) | Новый лиганд рецептора цитокина zcytor17 | |
| Gershon et al. | Early transcription factor subunits are encoded by vaccinia virus late genes. | |
| IL299249B1 (en) | Genetically modified immune cells that include adapted shrna-microRNA (shrnamir) | |
| JP2022536122A5 (https=) | ||
| JP2019511236A5 (https=) | ||
| JP2017018125A5 (https=) | ||
| CN114262690A (zh) | 减毒的痘苗病毒的克隆毒株及其使用方法 | |
| WO1992001049A3 (en) | Cd53 cell surface antigen and use thereof | |
| WO2001070174A8 (en) | Vegf-modulated genes and methods employing them | |
| CN103160530B (zh) | 一种融合基因及其应用 | |
| JP2024116193A5 (https=) | ||
| JP2013523084A5 (https=) | ||
| JP2026063215A5 (https=) | ||
| RU2012147590A (ru) | Пептиды cdca5 и содержащие их вакцины | |
| JP2022535458A5 (https=) | ||
| JP2024503091A5 (https=) | ||
| CN116970058B (zh) | 针对tp53基因r249s突变的肿瘤新抗原多肽及其应用 | |
| CN113249408A (zh) | 一种靶向激活体液免疫和细胞免疫的核酸疫苗载体构建及应用 | |
| JP2023515806A5 (https=) | ||
| CN102178950B (zh) | 一种亚单位疫苗免疫佐剂及应用 | |
| JP2020127419A5 (https=) | ||
| JP2024534189A5 (https=) | ||
| CN108018267B (zh) | 一种靶向表观基因调控抗乙型肝炎病毒分子HBx1C及其应用 | |
| Acosta-Rivero et al. | Improvement of human interferon HUIFNα2 and HCV core protein expression levels in Escherichia coli but not of HUIFNα8 by using the tRNAAGA/AGG |